Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Civil Defense | 1 | 2021 | 109 | 0.710 |
Why?
|
Health Care Rationing | 2 | 2021 | 437 | 0.660 |
Why?
|
Standard of Care | 1 | 2021 | 564 | 0.600 |
Why?
|
Triage | 1 | 2021 | 977 | 0.490 |
Why?
|
Critical Care | 1 | 2021 | 2647 | 0.330 |
Why?
|
Surge Capacity | 1 | 2021 | 42 | 0.200 |
Why?
|
Receptors, Somatomedin | 1 | 2016 | 57 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2021 | 685 | 0.130 |
Why?
|
Triazines | 1 | 2016 | 315 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 1 | 2022 | 1007 | 0.120 |
Why?
|
Albumins | 1 | 2016 | 568 | 0.110 |
Why?
|
Pandemics | 2 | 2021 | 8385 | 0.100 |
Why?
|
Education, Medical | 1 | 2022 | 1722 | 0.090 |
Why?
|
Students, Medical | 1 | 2022 | 1862 | 0.090 |
Why?
|
Paclitaxel | 1 | 2016 | 1705 | 0.080 |
Why?
|
Pyrazoles | 1 | 2016 | 1970 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1637 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5264 | 0.040 |
Why?
|
Social Justice | 1 | 2021 | 457 | 0.040 |
Why?
|
Somatomedins | 1 | 2016 | 192 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11524 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 461 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 2016 | 390 | 0.030 |
Why?
|
United States | 1 | 2021 | 69859 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23398 | 0.030 |
Why?
|
Drug Synergism | 1 | 2016 | 1794 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1876 | 0.030 |
Why?
|
Mice, SCID | 1 | 2016 | 2718 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1374 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 665 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3603 | 0.020 |
Why?
|
Aged | 1 | 2021 | 163178 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3547 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
Humans | 5 | 2022 | 743811 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11360 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10477 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9718 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40545 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16674 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81154 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168660 | 0.000 |
Why?
|
Female | 1 | 2016 | 380020 | 0.000 |
Why?
|
Concepts
(44)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_